Cannovum is a fully licensed pharmaceutical wholesaler, importer, and manufacturer of high-quality medical cannabis products based in Berlin. We focus on the import of medical cannabis, medical-scientific education and distribution for facilitated access to cannabis-based therapies.
Every patient deserves the best therapy. Medical cannabis can be a significant part of that therapy. Cannovum actively promotes access to cannabis for every patient that this form of therapy could help. As pioneers of the European cannabis revolution, the well-being of patients is our top priority.
Our Medical Advisory Board consists of experts and pioneers in cannabis therapy. The members of our board advise us with their scientific expertise and longterm practical experience. Head of the Medical Advisory Board is Dr. med. Dipl.-Chem. Konrad F. Cimander.
Dr. med. Dipl.-Chem. Konrad F. Cimander is an expert in addiction medicine, infectiology and cannabis therapy. He studied chemistry and human medicine at the WWU in Münster and received his doctorate in hand and accident surgery. After years of research in the pharmaceutical industry and development of new psychoactive medications, he founded the Competence Center for Addiction Medicine and Cannabis Therapy in 1993, which he still leads today. In addition to his former work as a university teacher for general medicine at the Hannover Medical School and the medical faculty of the University of Göttingen in the field of addiction, psychopharmacology, and prevention, Dr. Cimander is chairman and member of many medical associations. In 2020 he took over the scientific lead of the first Medicinal Cannabis Congress in Berlin and will once again do so in 2021. Especially important to him are scientific investigation and clarification of medical questions concerning the patients' well-being. Dr. Cimander consults Cannovum as 'Chief Medical Advisor'.
CEO & Co-Founder
Pia has dedicated her career to sustainable development, and, prior to founding Cannovum AG, she was in charge of operations for a regenerative energy company.
Pia is the CEO of the company and is committed to ensuring that every patient has access to the best therapy, which is why she takes part in the European Cannabis revolution.
Marius has spent thirteen years in various roles within the pharmaceutical industry, predominantly with an international focus. In his previous position as a project manager for Bayer, he introduced new processes and solutions for Bayer’s biological development in California and Germany. Marius believes that every patient deserves the best therapy, and is therefore proud to take part in the European Cannabis revolution.
Head of Quality Assurance
Timo received his PhD at the University of Bielefeld. While volunteering at DKMS to provide Leukemia patients with bone marrow donors, Timo began to espouse the idea that every patient should get the best treatment possible and have access to all forms of therapy. Together with scientists of the University of Bielefeld he researched smart microgel particles as a carrier system for cannabinoids. As Head of quality Assurance, he is responsible for the high quality of our products and ensures patients are provided with the best possible product.
Chairman Supervisory Board
Udo worked in the IT and telecommunications industry for almost 40 years. He started his career at IBM, then as Managing Director he led companies such as WANG, Data General and Nortel Networks in the DACH organization to extraordinary success. Today he advises medium-sized companies as a business consultant and is chairman of the supervisory board of the Cannovum AG.
Head of Marketing & Medical Affairs
Sandra has over 15 years of experience in the healthcare industry. Most recently, she ran development for the medical affairs department of an established Canadian medical cannabis manufacturer. As part of this role she was also responsible for building the company's educational platform.